Rachael Zemek Sarcoma Group, Cancer Centre Telethon Kids Institute Biography Publications Institution JoVE Articles Rachael ZemekDr Dr Rachael Zemek completed her PhD at the University of Western Australia and the National Centre of Asbestos Related Diseases in 2019. Here her project focused on thedivergent response to immune checkpoint blockade therapy for cancer, with the aim to identify biomarkers of response, as well as a way to pharmaceutically modulate the tumour to increase response rates. Rachael now works as a post-doctoral researcher in the Sarcoma Group at the Telethon Kids Institute. Here she is extending her research to target immune checkpoint resistant sarcoma tumours. Publications A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies Francois X. Rwandamuriye1,2, Breana J. Weston2,3, Terrance G. Johns2, W. Joost Lesterhuis1,2, Rachael M. Zemek2 1School of Biomedical Sciences, University of Western Australia, 2Telethon Kids Institute, University of Western Australia, 3College of Science, Health, Engineering and Education, Murdoch University JoVE 60882 Medicina
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies Francois X. Rwandamuriye1,2, Breana J. Weston2,3, Terrance G. Johns2, W. Joost Lesterhuis1,2, Rachael M. Zemek2 1School of Biomedical Sciences, University of Western Australia, 2Telethon Kids Institute, University of Western Australia, 3College of Science, Health, Engineering and Education, Murdoch University JoVE 60882 Medicina